218 related articles for article (PubMed ID: 9636057)
1. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
Komorowicz E; Kolev K; Machovich R
Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.
Kolev K; Tenekedjiev K; Komorowicz E; Machovich R
J Biol Chem; 1997 May; 272(21):13666-75. PubMed ID: 9153217
[TBL] [Abstract][Full Text] [Related]
3. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
Kolev K; Komorowicz E; Machovich R
Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
[TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.
Kolev K; Komorowicz E; Owen WG; Machovich R
Thromb Haemost; 1996 Jan; 75(1):140-6. PubMed ID: 8713793
[TBL] [Abstract][Full Text] [Related]
5. [Hydrolysis of polymeric fibrin by plasmin, miniplasmin, microplasmin and trypsin].
Andrianov SI; Makogonenko EM; Kudinov SA
Ukr Biokhim Zh (1978); 1992; 64(3):14-20. PubMed ID: 1440960
[TBL] [Abstract][Full Text] [Related]
6. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic resistance conferred to fibrinogen by von Willebrand factor.
Tanka-Salamon A; Kolev K; Machovich R; Komorowicz E
Thromb Haemost; 2010 Feb; 103(2):291-8. PubMed ID: 20024497
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
9. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
Anonick PK; Wolf B; Gonias SL
Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.
Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ
J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135
[TBL] [Abstract][Full Text] [Related]
14. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion.
Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Shibata A
Am J Hematol; 1991 Apr; 36(4):255-8. PubMed ID: 1826408
[TBL] [Abstract][Full Text] [Related]
15. Kringle domains and plasmin denaturation.
Shi GY; Wu DH; Wu HL
Biochem Biophys Res Commun; 1991 Jul; 178(1):360-8. PubMed ID: 1829887
[TBL] [Abstract][Full Text] [Related]
16. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
Kolev K; Léránt I; Tenekejiev K; Machovich R
J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
[TBL] [Abstract][Full Text] [Related]
17. Regulation of nonproteolytic active site formation in plasminogen.
Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
[TBL] [Abstract][Full Text] [Related]
18. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
Cheng AC; Tsai IH
Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
[TBL] [Abstract][Full Text] [Related]
20. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system.
Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E
J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]